With tax year end quickly approaching, we've rounded up the tranche close dates for a selection of key funds on our platform. To view all live investment opportunities or to access and digitally invest in any of the below funds, please sign in via coinvestor.co.uk.
Investments shown on this site put your capital at risk. View risk warning here.
Application Deadlines
Amberside Capital
Amberside Incrementum EIS - 31st March. Cheques last accepted 24th March
Amberside Knowledge Intensive EIS - 3rd April. Cheques last accepted 27th March
British Design Fund
The British Design Fund 2 - 31st March* (please note this has been extended)
Committed Capital
Committed Capital Growth EIS - 31st March
Great Point Investments Limited
Great Point Ventures EIS - 30th April: investing in 19/20 and 20/21
Guinness Asset Management
Guinness EIS - 6th March
Jenson Funding Partners
Jenson EIS Fund 19/20 - 24th March
Mercia Fund Management
Mercia EIS Fund - 27th March: investing in tax year 20/21
Newable Ventures Limited
Newable EIS Scale Up Fund 3 - 15th March
Nova
Nova Cofoundery SEIS and EIS Fund - 26th March
o2h Ventures Limited
o2h Therapeutics and AI S/EIS Fund - 15th March* (Please note this has been extended from 1st March)
RLC Ventures
Arrive Emerging Markets Tech SEIS/EIS Fund - 31st March
Station12
Station12 Sports, Entertainment and Knowledge Service - 13th March
Symvan Capital Limited
Symvan Technology EIS Fund - 27th March. Cheques last accepted 20th March
The SidebySide Partnership
The SBS Later Stage EIS Fund - 31st March
Vala Capital
Vala EIS - 30th March
Velocity Capital Advisors
Velocity EIS Technology Fund 5 - 2nd April
Velocity SEIS Technology Fund 4 - 1st April
If you have any questions or would like further information on how CoInvestor works, please get in touch via contact@coinvestor.co.uk.
As with all investments, the offers shown on the CoInvestor platform will place your capital at risk: Investors may not get back the full amount invested. The investments listed are unlisted companies which are likely to be harder to value and sell than quoted shares. Read full risk warning
